Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Free Cash Flow Generation Index
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥42.56 Million represents 1% of operating cash flow (CN¥52.93 Million). Explore Shanxi C&Y Pharmaceutical Group Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanxi C&Y Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for Shanxi C&Y Pharmaceutical Group Co Ltd across 16 annual periods. For the full cash flow conversion analysis, see Shanxi C&Y Pharmaceutical Group Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Shanxi C&Y Pharmaceutical Group Co Ltd (2009–2025)
Year-by-year Free Cash Flow Generation Index for Shanxi C&Y Pharmaceutical Group Co Ltd. Check 300254 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | CN¥62.45 Million | CN¥96.77 Million | CN¥34.32 Million | ▲ +135.5% |
| 2024 | 0.27x | CN¥19.44 Million | CN¥70.94 Million | CN¥51.50 Million | ▲ +165.8% |
| 2023 | 0.10x | CN¥3.90 Million | CN¥37.81 Million | CN¥33.92 Million | ▼ -84.0% |
| 2022 | 0.64x | CN¥48.09 Million | CN¥74.88 Million | CN¥26.78 Million | ▲ +3.8% |
| 2021 | 0.62x | CN¥59.99 Million | CN¥96.92 Million | CN¥36.93 Million | ▼ -15.6% |
| 2019 | 0.73x | CN¥51.09 Million | CN¥69.63 Million | CN¥18.54 Million | ▲ +218.7% |
| 2018 | 0.23x | CN¥8.85 Million | CN¥38.44 Million | CN¥29.59 Million | ▲ +115.1% |
| 2017 | -1.52x | CN¥-60.97 Million | CN¥40.10 Million | CN¥101.07 Million | ▼ -593.5% |
| 2016 | -0.22x | CN¥-9.13 Million | CN¥41.65 Million | CN¥50.78 Million | ▲ +83.3% |
| 2015 | -1.31x | CN¥-20.24 Million | CN¥15.44 Million | CN¥35.68 Million | ▼ -324.5% |
| 2014 | 0.58x | CN¥47.99 Million | CN¥82.19 Million | CN¥34.20 Million | ▲ +107.5% |
| 2013 | 0.28x | CN¥22.67 Million | CN¥80.58 Million | CN¥57.91 Million | ▲ +195.5% |
| 2012 | -0.29x | CN¥-10.33 Million | CN¥35.05 Million | CN¥45.38 Million | ▲ +97.7% |
| 2011 | -12.90x | CN¥-61.28 Million | CN¥4.75 Million | CN¥66.03 Million | ▼ -15875.5% |
| 2010 | 0.08x | CN¥4.26 Million | CN¥52.03 Million | CN¥47.78 Million | ▼ -90.7% |
| 2009 | 0.88x | CN¥93.22 Million | CN¥105.55 Million | CN¥12.33 Million | — |